Categories Earnings, Health Care
Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for the fourth quarter of 2023.
- Fourth-quarter revenues increased 9% annually to $901.6 million; organic revenue growth was 8%
- Net income attributable to shareholders moved up to $194.52 million from $172.2 million a year earlier
- On a per-share basis, fourth-quarter earnings rose to $2.32 per share from $2.05 per share in Q4 2022
- For fiscal 2024, the management expects revenues to be in the range of $3.93 billion to $4.04 billion, reflecting a growth of 7.5-10.5%
- Full-year organic revenue growth is expected to be between 7% and 10%
- The management is looking for earnings of $10.84 per share to $11.33 per share for FY24, an increase of 8-13% as reported and on a comparable basis
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
BLK Q4 Preview: BlackRock appears poised for another earnings beat
BlackRock, Inc. (NYSE: BLK), the largest asset management company, is set to publish its fourth-quarter 2025 results next week. The update is expected to shed light on how the firm’s
A look at Best Buy’s (BBY) progress on its growth strategy
Shares of Best Buy Co., Inc. (NYSE: BBY) fell over 3% on Wednesday. The stock has dropped 17% over the past 12 months. The consumer electronics retailer delivered sales and
